{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:52:04Z","timestamp":1791917524610,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1245\/s10434-016-5606-4","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T16:10:39Z","timestamp":1475511039000},"page":"1048-1054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy"],"prefix":"10.1245","volume":"23","author":[{"given":"Yosuke","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yunaiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Gondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tokuuye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"5606_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.urology.2006.01.043","volume":"67","author":"CP Dinney","year":"2006","unstructured":"Dinney CP. Therapy of invasive bladder cancer. Urology. 2006;67:56\u20139.","journal-title":"Urology"},{"key":"5606_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.urology.2006.10.040","volume":"69","author":"SB Malkowicz","year":"2007","unstructured":"Malkowicz SB, van Poppel H, Mickisch G, et al. Muscle-invasive urothelial carcinoma of the bladder. Urology. 2007;69:3\u201316.","journal-title":"Urology"},{"key":"5606_CR3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","volume":"349","author":"HB Grossman","year":"2003","unstructured":"Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859\u201366.","journal-title":"N Engl J Med."},{"key":"5606_CR4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","volume":"48","author":"Neoadjuvant chemotherapy in invasive bladder cancer","year":"2005","unstructured":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202\u20135.","journal-title":"Eur Urol."},{"key":"5606_CR5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.juro.2006.09.027","volume":"177","author":"HW Herr","year":"2007","unstructured":"Herr HW, Dotan Z, Donat SM, et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177:437\u201343.","journal-title":"J Urol."},{"key":"5606_CR6","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1245\/s10434-011-1976-9","volume":"18","author":"MS Sabel","year":"2011","unstructured":"Sabel MS, Lee J, Cai S, et al. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18:3579\u201385.","journal-title":"Ann Surg Oncol."},{"key":"5606_CR7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629\u201335.","journal-title":"Lancet Oncol."},{"key":"5606_CR8","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol."},{"key":"5606_CR9","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","volume":"15","author":"BH Tan","year":"2009","unstructured":"Tan BH, Birdsell LA, Martin L, et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973\u20139.","journal-title":"Clin Cancer Res."},{"key":"5606_CR10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.surg.2015.02.002","volume":"157","author":"S Okumura","year":"2015","unstructured":"Okumura S, Kaido T, Hamaguchi Y, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088\u201398.","journal-title":"Surgery."},{"key":"5606_CR11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1634\/theoncologist.2012-0169","volume":"17","author":"E Fabbro Del","year":"2012","unstructured":"Del Fabbro E, Parsons H, Warneke CL, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17:1240\u20135.","journal-title":"Oncologist."},{"key":"5606_CR12","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","volume":"22","author":"Y Miyamoto","year":"2015","unstructured":"Miyamoto Y, Baba Y, Sakamoto Y, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22:2663\u20138.","journal-title":"Ann Surg Oncol."},{"key":"5606_CR13","doi-asserted-by":"crossref","unstructured":"Fukushima H, Nakanishi Y, Kataoka M, et al. Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J Urol. In press.","DOI":"10.1016\/j.juro.2015.08.071"},{"key":"5606_CR14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","volume":"100","author":"N Harimoto","year":"2013","unstructured":"Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523\u201330.","journal-title":"Br J Surg."},{"key":"5606_CR15","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.28798","volume":"120","author":"SP Psutka","year":"2014","unstructured":"Psutka SP, Carrasco A, Schmit GD, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014;120:2910\u201318.","journal-title":"Cancer."},{"key":"5606_CR16","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.juro.2013.12.047","volume":"191","author":"AB Smith","year":"2014","unstructured":"Smith AB, Deal AM, Yu H, et al. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol. 2014;191:1714\u201320.","journal-title":"J Urol."},{"key":"5606_CR17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97:2333\u20138.","journal-title":"J Appl Physiol."},{"key":"5606_CR18","doi-asserted-by":"crossref","first-page":"e0115895","DOI":"10.1371\/journal.pone.0115895","volume":"10","author":"H Fukushima","year":"2015","unstructured":"Fukushima H, Yokoyama M, Nakanishi Y, et al. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One. 2015;10:e0115895.","journal-title":"PLoS One."},{"key":"5606_CR19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-12-6","volume":"12","author":"T Letilovic","year":"2013","unstructured":"Letilovic T, Perkov S, Mestric ZF, et al. Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure\u2014is there only one cachexia? Nutr J. 2013;12:6.","journal-title":"Nutr J."},{"key":"5606_CR20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","volume":"22","author":"JM Argiles","year":"2015","unstructured":"Argiles JM, Busquets S, Stemmler B, et al. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100\u20136.","journal-title":"Curr Opin Pharmacol."},{"key":"5606_CR21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10:90\u20139.","journal-title":"Nat Rev Clin Oncol."},{"key":"5606_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol."},{"key":"5606_CR23","doi-asserted-by":"crossref","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","volume":"91","author":"WJ Evans","year":"2010","unstructured":"Evans WJ. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin Nutr. 2010;91:1123S\u20137S.","journal-title":"Am J Clin Nutr."},{"key":"5606_CR24","doi-asserted-by":"crossref","first-page":"e41883","DOI":"10.1371\/journal.pone.0041883","volume":"7","author":"CH Richards","year":"2012","unstructured":"Richards CH, Roxburgh CS, MacMillan MT, et al. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One. 2012;7:e41883.","journal-title":"PLoS One."},{"key":"5606_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","volume":"62","author":"S Dodson","year":"2011","unstructured":"Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011;62:265\u201379.","journal-title":"Annu Rev Med."},{"key":"5606_CR26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","volume":"79","author":"T Gondo","year":"2012","unstructured":"Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79:1085\u201391.","journal-title":"Urology."},{"key":"5606_CR27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6603415","volume":"95","author":"M Hilmy","year":"2006","unstructured":"Hilmy M, Campbell R, Bartlett JM, et al. The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer. 2006;95:1234\u20138.","journal-title":"Br J Cancer."},{"key":"5606_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","volume":"58","author":"H Cho","year":"2009","unstructured":"Cho H, Hur HW, Kim SW, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58:15\u201323.","journal-title":"Cancer Immunol Immunother."},{"key":"5606_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000437005","volume":"130","author":"R Malhotra","year":"2015","unstructured":"Malhotra R, Marcelli D, von Gersdorff G, et al. Relationship of neutrophil-to-lymphocyte ratio and serum albumin levels with C-reactive protein in hemodialysis patients: results from 2 international cohort studies. Nephron. 2015;130:263\u201370.","journal-title":"Nephron."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5606-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5606-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5606-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:15:29Z","timestamp":1498349729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5606-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":29,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["5606"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5606-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}